Merck
CN
  • Combination of BMP2 and MSCs significantly increases bone formation in the rat arterio-venous loop model.

Combination of BMP2 and MSCs significantly increases bone formation in the rat arterio-venous loop model.

Tissue engineering. Part A (2014-08-20)
Gregor Buehrer, Amelie Balzer, Isabel Arnold, Justus P Beier, Carolin Koerner, Oliver Bleiziffer, Andreas Brandl, Christian Weis, Raymund E Horch, Ulrich Kneser, Andreas Arkudas
摘要

In this study the induction of bone formation in an axially vascularized bone matrix using mesenchymal stem cells (MSCs) and application of bone morphogenetic protein 2 (BMP2) was analyzed in the arteriovenous loop (AVL) model. An AVL was created in the medial thigh of 42 rats and placed in a porous titanium chamber filled with a particulated porous hydroxyapatite and beta-tricalcium phosphate matrix and fibrin. In group A the fibrin was loaded with 5×10(6) DiI-stained fibrin gel-immobilized primary MSCs from syngenic Lewis rats, in group B the matrix was loaded with 60 μg/mL BMP2 and in group C both, BMP2 and MSCs were applied at implantation time point. After 6 and 12 weeks, specimens were investigated by means of histological, morphometrical, and micro-computed tomography analysis. After implantation of an AVL a dense vascular network was visible in all groups. In group A, newly generated bone islands were detected in the periphery of the main vascular axis. Using BMP2 alone (group B), small islands of newly formed bone were visible evenly distributed in all parts of the constructs. In group C nearly the whole matrix was interspersed with bone formations. In all groups there was an increase of bone formation between the 6 and 12 weeks explantation time points. This study demonstrates for the first time the successful generation of axially vascularized bone substitutes using MSCs and BMP2 in the AVL rat model using a one step procedure. Using the combination of BMP2 and MSCs there was a significant increase of bone formations detectable compared to the BMP2 or MSCs alone groups.

材料
货号
品牌
产品描述

Sigma-Aldrich
乙二胺四乙酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
D -甘露醇, ≥98% (GC)
Sigma-Aldrich
乙二胺四乙酸 二钠盐 溶液, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
Supelco
甘露醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
乙二胺四乙酸, BioUltra, anhydrous, ≥99% (titration)
Sigma-Aldrich
乙二胺四乙酸 溶液, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
D -甘露醇, ACS reagent
Sigma-Aldrich
苏木精, certified by the Biological Stain Commission
Sigma-Aldrich
乙二胺四乙酸, purified grade, ≥98.5%, powder
Sigma-Aldrich
乙二胺四乙酸, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
羟基磷灰石, nanopowder, <200 nm particle size (BET), ≥97%, synthetic
Sigma-Aldrich
苏木精
Sigma-Aldrich
D -甘露醇, BioXtra, ≥98% (HPLC)
Sigma-Aldrich
乙二胺四乙酸, 99.995% trace metals basis
Sigma-Aldrich
羟基磷灰石, reagent grade, powder, synthetic
Sigma-Aldrich
D -甘露醇, ≥98% (GC), suitable for plant cell culture
Sigma-Aldrich
D -甘露醇, meets EP, FCC, USP testing specifications
Sigma-Aldrich
β-磷酸三钙, puriss. p.a., ≥98% β-phase basis (sintered Powder)
Sigma-Aldrich
1,1′-二十八烷基-3,3,3′,3′-四甲基吲哚菁高氯酸盐, BioReagent, suitable for fluorescence, ≥98.0% (TLC)
Sigma-Aldrich
1,1′-二十八烷基-3,3,3′,3′-四甲基吲哚菁高氯酸盐, 97%
甘露醇, European Pharmacopoeia (EP) Reference Standard
USP
甘露醇, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
β-磷酸三钙, puriss. p.a., ≥98% β-phase basis (unsintered powder)
Millipore
D -甘露醇, ACS reagent, suitable for microbiology, ≥99.0%
Sigma-Aldrich
乙二胺四乙酸, ≥98.0% (KT)
Sigma-Aldrich
D -甘露醇, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
乙二胺四乙酸, BioUltra, ≥99.0% (KT)
Sigma-Aldrich
羟基磷灰石, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sigma-Aldrich
羟基磷灰石, purum p.a., ≥90% (as Ca3(PO4)2, KT)
Sigma-Aldrich
磷酸钙 三元, 34.0-40.0% Ca basis